Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes.

Sasakabe T, Haimoto H, Umegaki H, Wakai K.

Diabetes Metab Syndr Obes. 2011;4:167-74. doi: 10.2147/DMSO.S19635. Epub 2011 Apr 29.

2.

Japanese dietary lifestyle and cardiovascular disease.

Tada N, Maruyama C, Koba S, Tanaka H, Birou S, Teramoto T, Sasaki J.

J Atheroscler Thromb. 2011;18(9):723-34. Epub 2011 Jun 17. Review.

3.

Fad diets in the treatment of diabetes.

Feinman RD.

Curr Diab Rep. 2011 Apr;11(2):128-35. doi: 10.1007/s11892-011-0178-y.

PMID:
21234818
4.

Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies.

Fung TT, van Dam RM, Hankinson SE, Stampfer M, Willett WC, Hu FB.

Ann Intern Med. 2010 Sep 7;153(5):289-98. doi: 10.7326/0003-4819-153-5-201009070-00003.

5.

Are refined carbohydrates worse than saturated fat?

Hu FB.

Am J Clin Nutr. 2010 Jun;91(6):1541-2. doi: 10.3945/ajcn.2010.29622. Epub 2010 Apr 21. No abstract available.

6.

Trends in nutrient intake among adults with diabetes in the United States: 1988-2004.

Oza-Frank R, Cheng YJ, Narayan KM, Gregg EW.

J Am Diet Assoc. 2009 Jul;109(7):1173-8. doi: 10.1016/j.jada.2009.04.007.

PMID:
19559133
7.

Kidney protection: a key target in the management of patients with diabetes.

Ruilope LM, Segura J.

J Hypertens Suppl. 2009 May;27(1):S15-8. doi: 10.1097/01.hjh.0000354419.15934.84.

PMID:
19483503
8.

Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes.

Haimoto H, Sasakabe T, Wakai K, Umegaki H.

Nutr Metab (Lond). 2009 May 6;6:21. doi: 10.1186/1743-7075-6-21.

9.

Revised equations for estimated GFR from serum creatinine in Japan.

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR.

Am J Kidney Dis. 2009 Jun;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034. Epub 2009 Apr 1.

PMID:
19339088
10.

Insulin resistance is an independent correlate of increased urine albumin excretion: a cross-sectional study in Iranian Type 2 diabetic patients.

Esteghamati A, Ashraf H, Nakhjavani M, Najafian B, Hamidi S, Abbasi M.

Diabet Med. 2009 Feb;26(2):177-81. doi: 10.1111/j.1464-5491.2008.02653.x.

PMID:
19236623
11.

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus.

Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR.

Nutr Metab (Lond). 2008 Dec 19;5:36. doi: 10.1186/1743-7075-5-36.

12.

Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.

Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, Kraemer WJ, Bibus DM, Fernandez ML, Feinman RD.

Lipids. 2009 Apr;44(4):297-309. doi: 10.1007/s11745-008-3274-2. Epub 2008 Dec 12.

PMID:
19082851
13.

Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes.

Ikeda H, Hamamoto Y, Honjo S, Nabe K, Wada Y, Koshiyama H.

Diabetes Res Clin Pract. 2009 Jan;83(1):117-8. doi: 10.1016/j.diabres.2008.10.013. Epub 2008 Dec 5.

PMID:
19062123
14.

Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.

Araki S, Haneda M, Koya D, Kashiwagi A, Uzu T, Kikkawa R.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S54-8. doi: 10.1016/j.diabres.2008.09.031. Epub 2008 Oct 22. Review.

PMID:
18947896
15.

Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?

Bilous R.

Diabet Med. 2008 Aug;25 Suppl 2:25-9. doi: 10.1111/j.1464-5491.2008.02496.x.

PMID:
18717975
16.

Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal.

Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, Gleed A, Jacobs DB, Larson G, Lustig RH, Manninen AH, McFarlane SI, Morrison K, Nielsen JV, Ravnskov U, Roth KS, Silvestre R, Sowers JR, Sundberg R, Volek JS, Westman EC, Wood RJ, Wortman J, Vernon MC.

Nutr Metab (Lond). 2008 Apr 8;5:9. doi: 10.1186/1743-7075-5-9.

17.

Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?

Basi S, Fesler P, Mimran A, Lewis JB.

Diabetes Care. 2008 Feb;31 Suppl 2:S194-201. doi: 10.2337/dc08-s249. Review. No abstract available.

PMID:
18227485
18.

Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.

Chapman MJ, Sposito AC.

Pharmacol Ther. 2008 Mar;117(3):354-73. doi: 10.1016/j.pharmthera.2007.10.004. Epub 2007 Dec 14. Review.

PMID:
18215759
19.

Standards of medical care in diabetes--2008.

American Diabetes Association.

Diabetes Care. 2008 Jan;31 Suppl 1:S12-54. doi: 10.2337/dc08-S012. No abstract available.

PMID:
18165335
20.

Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: a 2-year follow-up study.

Haimoto H, Iwata M, Wakai K, Umegaki H.

Diabetes Res Clin Pract. 2008 Feb;79(2):350-6. Epub 2007 Nov 5.

PMID:
17980451

Supplemental Content

Support Center